Answers are grounded in this paper and cite their sources.
Omadacycline is an aminomethylcycline antibiotic with in vitro activity against pathogens causing community-acquired bacterial pneumonia (CABP). This study investigated the activity of omadacycline against Legionella pneumophila strains isolated between 1995 and 2014 from nosocomial or community-acquired respiratory infections. Omadacycline exhibited extracellular activity similar to comparator antibiotics; intracellular penetrance was found by day 3 of omadacycline exposure.
No takes yet. Share an insight, caveat, or question.
Dubois et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: